Skip to content

Effects of rush immunotherapy for Dermatophagoides

Effects of rush immunotherapy for Dermatophagoides - Effects of rush immunotherapy for Dermatophagoides

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019132
Enrollment
50
Registered
2015-09-28
Start date
2015-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis, Bronchial asthma

Interventions

blood test(pre, 1week, 1month, 3month, half-year, one-year, 10ml per time), bronchial challenge test(pre, one-year), spirometry(every visit, up to one-year), FeNO(every visit, up to one-year), Forced

Sponsors

Sagamihara National Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. >=5 years old, <18 years old 2. Positive with specific IgE of Dermatophagoides 3. Patient with allergic rhinitis or bronchial asthma(atopic) 4. No current other immunotherapy 5. In bronchial asthma: %FEV1.0>70, using ICS, not using omalizumab, mild intermittent asthma

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
QOL or Symptoms of allergic rhinitis or bronchial asthma (after one year)

Secondary

MeasureTime frame
QOL or Symptoms of allergic rhinitis or bronchial asthma (per visit) Specific IgE, basophil activation test, specific IgG4, Forced Oscillation Technique, lung function, Fractional exhaled nitric oxide, and so on

Countries

Japan

Contacts

Public ContactTomoyuki Asaumi

Sagamihara National Hospital Pediatrics

Ocean19oranges@yahoo.co.jp042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026